Baird Financial Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Hold |
14,299
| – | – | ﹤0.01% | 1439 |
|
|
2025
Q1 | $540K | Buy |
14,299
+2,523
| +21% | +$95.3K | ﹤0.01% | 1371 |
|
|
2024
Q4 | $964K | Sell |
11,776
-2,341
| -17% | -$192K | ﹤0.01% | 1191 |
|
|
2024
Q3 | $1.61M | Sell |
14,117
-5,016
| -26% | -$573K | ﹤0.01% | 1027 |
|
|
2024
Q2 | $1.44M | Buy |
19,133
+2,660
| +16% | +$201K | ﹤0.01% | 1053 |
|
|
2024
Q1 | $1.13M | Sell |
16,473
-26,984
| -62% | -$1.84M | ﹤0.01% | 1128 |
|
|
2023
Q4 | $2.73M | Buy |
+43,457
| New | +$2.73M | 0.01% | 849 |
|